Disease-Modifying Effects of M1 Muscarinic Acetylcholine Receptor Activation in an Alzheimer's Disease Mouse Model (original) (raw)
Loss of Muscarinic M 1 Receptor Exacerbates Alzheimer's Disease–Like Pathology and Cognitive Decline
Frank LaFerla
Asian Journal of Psychiatry, 2011
View PDFchevron_right
Deletion of M1 Muscarinic Acetylcholine Receptors Increases Amyloid Pathology In Vitro and In Vivo
James Lah
Journal of Neuroscience, 2010
View PDFchevron_right
Cholinergic modulation of amyloid precursor protein processing with emphasis on M1 muscarinic receptor: perspectives and challenges in treatment of Alzheimer’s disease
Abraham Fisher
Journal of Neurochemistry, 2012
View PDFchevron_right
Muscarinic acetylcholine receptor-expression in astrocytes in the cortex of young and aged rats
E. Van Der Zee
Glia, 1993
View PDFchevron_right
Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice
Nancy Rahnama, Alcino Silva
Nature Neuroscience, 2002
View PDFchevron_right
Blockade of Tau Hyperphosphorylation and Aβ1–42 Generation by the Aminotetrahydrofuran Derivative ANAVEX2-73, a Mixed Muscarinic and σ1 Receptor Agonist, in a Nontransgenic Mouse Model of Alzheimer’s Disease
Johann Meunier
Neuropsychopharmacology, 2013
View PDFchevron_right
The Potential for Muscarinic Receptor Subtype-Specific Pharmacotherapy for Alzheimer's Disease
Joseph T Coyle
Mayo Clinic Proceedings, 1991
View PDFchevron_right
Quirion R, Wilson A, Rowe W, Aubert I, Richard J, Doods H et al. Facilitation of acetylcholine release and cognitive performance by an M(2)-muscarinic receptor antagonist in aged memory-impaired. J Neurosci 15: 1455-1462
Henri Doods
The Journal of Neuroscience : The Official Journal of the Society for Neuroscience
View PDFchevron_right
M1 Muscarinic Agonists Can Modulate Some of the Hallmarks in Alzheimer's Disease: Implications in Future Therapy
Abraham Fisher
Journal of Molecular Neuroscience, 2003
View PDFchevron_right
Cholinergic Treatments With Emphasis on M1 Muscarinic Agonists As Potential Disease-Modifying Agents for Alzheimer's Disease
Abraham Fisher
Neurotherapeutics: the journal of the American Society …, 2008
View PDFchevron_right
M1 Agonists for the Treatment of Alzheimer's Disease
Daniele Marciano
Annals of the New York Academy of Sciences, 1996
View PDFchevron_right
The selective muscarinic M1 agonist AF102B decreases levels of total A? in cerebrospinal fluid of patients with Alzheimer's disease
Marsha Tennis
Annals of Neurology, 2000
View PDFchevron_right
Activation of M1 and M4 muscarinic receptors as potential treatments for Alzheimer's disease and schizophrenia
Jeffrey Conn
Neuropsychiatric Disease and Treatment, 2014
View PDFchevron_right
Muscarinic receptors and novel strategies for the treatment of age-related brain disorders
William Roeske
Life Sciences, 1994
View PDFchevron_right
M1 muscarinic receptor activation protects neurons from β-amyloid toxicity. A role for Wnt signaling pathway
Juan Godoy
Neurobiology of Disease, 2004
View PDFchevron_right
AF710B, a Novel M1/σ1 Agonist with Therapeutic Efficacy in Animal Models of Alzheimer's Disease
Abraham Fisher
Neuro-degenerative diseases, 2015
View PDFchevron_right
Uncoupling of M1 muscarinic receptor/G-protein interaction by amyloid β1–42
Vladimír Doležal
Neuropharmacology, 2013
View PDFchevron_right
Novel m1 muscarinic agonists in treatment and delaying the progression of Alzheimer's disease: An unifying hypothesis
Abraham Fisher
Journal of Physiology-Paris, 1998
View PDFchevron_right
M1 Muscarinic Receptor Activation Protects Neurons From [Beta]-Amyloid Toxicity. A Role for Wnt Signaling Pathway
Ginny Farías
Neurobiology of …, 2004
View PDFchevron_right
M2 Muscarinic Acetylcholine Receptor Knock-Out Mice Show Deficits in Behavioral Flexibility, Working Memory, and Hippocampal Plasticity
Irina Fedorova
Journal of Neuroscience, 2004
View PDFchevron_right
M1-M3 Muscarinic Acetylcholine Receptor-Deficient Mice: Novel Phenotypes
Dinesh Gautam
Journal of Molecular Neuroscience, 2006
View PDFchevron_right
Selective activation of the M1 muscarinic acetylcholine receptor achieved by allosteric potentiation
Marlene Jacobson
Proceedings of the National Academy of Sciences, 2009
View PDFchevron_right
M 1 –M 3 muscarinic acetylcholine receptor-deficient mice
Dinesh Gautam
Journal of Molecular Neuroscience, 2006
View PDFchevron_right
Loss of muscarinic M4 receptors in hippocampus of Alzheimer patients 2003
Abdu Adem
View PDFchevron_right
Discrete activation of transduction pathways associated with acetylcholine m1 receptor by several muscarinic ligands
Abraham Fisher
European Journal of Pharmacology: Molecular Pharmacology, 1994
View PDFchevron_right
Inhibitor of antagonist binding to the muscarinic receptor is elevated in Alzheimer's brain
Thomas Ala
Brain Research, 1994
View PDFchevron_right
Selective Signaling via Unique Ml Muscarinic Agonistsa
Daniele Marciano
Annals of the New York Academy of Sciences, 1993
View PDFchevron_right
Acetylcholine Muscarinic M2 Receptor Stimulated [35S]GTPγS Binding Shows Regional Selective Changes in Alzheimer's Disease Postmortem Brain
rivka ravid
Neurodegeneration, 1996
View PDFchevron_right
Dysregulated hippocampal acetylcholine neurotransmission and impaired cognition in M2, M4 and M2/M4 muscarinic receptor knockout mice
Christian Felder
Molecular Psychiatry, 2003
View PDFchevron_right
Cortical M1 receptor concentration increases without a concomitant change in function in Alzheimer's disease
Christian Felder
Journal of chemical neuroanatomy, 2010
View PDFchevron_right
A Selective Allosteric Potentiator of the M1 Muscarinic Acetylcholine Receptor Increases Activity of Medial Prefrontal Cortical Neurons and Restores Impairments in Reversal Learning
Michelle Nicolle
Journal of Neuroscience, 2009
View PDFchevron_right
M1 muscarinic receptor signaling in mouse hippocampus and cortex
Christian Felder
Brain Research, 2002
View PDFchevron_right